Reducing cardiovascular risk in children born with poor fetal growth: the Small baby Omega-3 (SO3) trial

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1078142

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Poor fetal growth affects about 10% of people, and is a risk factor for high blood pressure and heart disease in adults. There is no current treatment to reduce the increased risk of heart disease due to poor fetal growth. This study will determine whether taking fish oils during infancy reduces arterial wall thickness, a sign of the disease that causes the majority of heart attacks, and lowers blood pressure in children who had poor fetal growth.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $999,791.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

atherosclerosis | blood pressure | clinical trial | fetal origins of disease | omega-3 fatty acids

Related Links